<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Merrimack Pharmaceuticals, Inc.

    Merrimack Pharmaceuticals, Inc.

    Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is...

    Merrimack is a biopharmaceutical company based ...

    Filing Type:    PU
    Solid Biosciences Inc.

    Solid Biosciences Inc.

    Solid Biosciences is a life science company focused solely on finding meaningful t...

    Solid Biosciences is a life science company foc...

    Filing Type:    PU
    Stealth BioTherapeutics Corp.

    Stealth BioTherapeutics Corp.

    We are an innovative biopharmaceutical company developing therapies to treat the m...

    We are an innovative biopharmaceutical company ...

    Filing Type:    PU
    Regulus Therapeutics Inc.

    Regulus Therapeutics Inc.

    Regulus Therapeutics Inc. (Nasdaq: RGLS) is a clinical stage biopharmaceutical com...

    Regulus Therapeutics Inc. (Nasdaq: RGLS) is a c...

    Filing Type:    PU
    Catabasis Pharmaceuticals, Inc.

    Catabasis Pharmaceuticals, Inc.

    At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing thera...

    At Catabasis Pharmaceuticals, our mission is to...

    Filing Type:    PU
    FibroGen, Inc

    FibroGen, Inc

    FibroGen, Inc. is a leading science-based biopharmaceutical company discovering an...

    FibroGen, Inc. is a leading science-based bioph...

    Filing Type:    PU
    Gritstone Oncology, Inc.

    Gritstone Oncology, Inc.

    Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight mu...

    Gritstone Oncology is developing tumor-specific...

    Filing Type:    PU
    Onconova Therapeutics, Inc.

    Onconova Therapeutics, Inc.

    Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused o...

    Onconova Therapeutics, Inc. is a Phase 3-stage ...

    Filing Type:    PU
    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    Phormed Inc

    Phormed Inc

    PhorMed is a clinical stage biopharmaceutical company located in Beverly Hills Cal...

    PhorMed is a clinical stage biopharmaceutical c...

    Amount Raised:    $128,700.00
    Fundraising Status:    EC
    Filing Type:    CF
    Gossamer Bio, Inc.

    Gossamer Bio, Inc.

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering,...

    Gossamer Bio is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.